#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2341662	F	Antidiabetic activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as reduction in visceral fat accumulation at 56 umol/kg, ip bid for 50 days measured on day 50 relative to control	Mus musculus	1		organism-based format	Scientific Literature
2.	ALA2341663	F	Antidiabetic activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as increase in ratio HDL/LDL at 56 umol/kg, ip bid for 50 days measured on day 50 relative to control	Mus musculus	1		organism-based format	Scientific Literature
3.	ALA2341664	F	Antioxidant activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as reduction in plasma malondialdehyde level at 56 umol/kg, ip bid for 50 days measured on day 50 relative to control	Mus musculus	1		organism-based format	Scientific Literature
4.	ALA2341665	F	Antidiabetic activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as maintenance of initial triglyceride level at 56 umol/kg, ip bid for 50 days	Mus musculus	1		organism-based format	Scientific Literature
5.	ALA2341666	F	Antidiabetic activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as maintenance of initial HDL level at 56 umol/kg, ip bid for 50 days	Mus musculus	1		organism-based format	Scientific Literature
6.	ALA2341667	F	Antidiabetic activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as reduction in plasma LDL level at 56 umol/kg, ip bid for 50 days measured on day 50 relative to control	Mus musculus	1		organism-based format	Scientific Literature
7.	ALA2341668	F	Antidiabetic activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as reduction in plasma LDL level at 56 umol/kg, ip bid for 50 days measured on day 43 relative to control	Mus musculus	1		organism-based format	Scientific Literature
8.	ALA2341669	F	Antidiabetic activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as reduction in plasma total cholesterol level at 56 umol/kg, ip bid for 50 days measured on day 50 relative to control	Mus musculus	1		organism-based format	Scientific Literature
9.	ALA2341670	F	Antidiabetic activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as reduction in plasma total cholesterol level at 56 umol/kg, ip bid for 50 days measured on day 43 relative to control	Mus musculus	1		organism-based format	Scientific Literature
10.	ALA2341671	T	Toxicity in high diet fed streptozotocin-challenged SKH2 mouse assessed as increase in food intake at 56 umol/kg, ip bid for 50 days relative to control	Mus musculus	1		organism-based format	Scientific Literature
11.	ALA2341672	F	Antidiabetic activity against high diet fed SKH2 mouse assessed as decrease in streptozotocin-induced rise in blood glucose level at 56 umol/kg, ip bid for 50 days	Mus musculus	1		organism-based format	Scientific Literature
12.	ALA2341673	T	Toxicity in high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model at 56 umol/kg, ip bid for 50 days	Mus musculus	1		organism-based format	Scientific Literature
13.	ALA2341674	F	Antidiabetic activity against high diet fed streptozotocin-challenged SKH2 mouse type 2 diabetes model assessed as change in body weight at 56 umol/kg, ip bid for 50 days measured up to day 35	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA2339317	F	Antiinflammatory activity in SKH2 mouse assessed as reduction in carrageenan-induced paw edema at 0.3 mmol/kg, ip after carrageenan challenge measured after 3.5 hrs relative to control	Mus musculus	3		organism-based format	Scientific Literature
15.	ALA2339318	F	Antioxidant activity rat assessed as reduction in plasma malondialdehyde level at 56 umol/kg, ip after 24 hrs relative to control	Rattus norvegicus	2		organism-based format	Scientific Literature
16.	ALA2339319	F	Antidyslipidemic activity against triton WR1339-induced hyperlipidemia in rat assessed as reduction in plasma triglyceride level at 56 umol/kg, ip after 24 hrs (Rvb = 580%)	Rattus norvegicus	6		organism-based format	Scientific Literature
17.	ALA2339320	F	Antidyslipidemic activity against triton WR1339-induced hyperlipidemia in rat assessed as reduction in plasma total cholesterol level at 56 umol/kg, ip after 24 hrs (Rvb = 260%)	Rattus norvegicus	6		organism-based format	Scientific Literature
18.	ALA2339321	B	Inhibition of squalene synthase in rat liver microsomes assessed as inhibition of [3H] FPP conversion to squalene after 10 mins by scintillation counting analysis	Rattus norvegicus	3		microsome format	Scientific Literature
19.	ALA2339322	F	Antioxidant activity against CuSO4-induced human LDL oxidation assessed as increase in lag time incubated for 5 mins prior to CuSO4 addition measured every 10 mins for 5 hrs by spectrophotometric analysis relative to control		2		assay format	Scientific Literature
20.	ALA2339323	F	Antioxidant activity against CuSO4-induced human LDL oxidation assessed as amount of dienes formed in decomposition phase at 1 uM incubated for 5 mins prior to CuSO4 addition measured every 10 mins for 5 hrs by spectrophotometric analysis (Rvb = 490.9 nmol/mg)		2		assay format	Scientific Literature